for future administration of dacarbazine in malignant melanoma ( a ) patients with pre-existent liver disease should be excluded from dtic-treatment , ( b ) the prodromi and cardinal symptoms should be carefully registered and ( c ) high dosage corticosteroid therapy with fibrinolytic measures should be immediately administered .
C0025202
malignant melanoma
C0010927
dtic